Medical device company DexCom (NASDAQ:DXCM) saw its shares gain a stately 31.5% during the month of April, according to data from S&P Global Market Intelligence.Thanks to strong demand for its continuous glucose monitoring (CGM) devices, DexCom topped analysts' Q1 revenue estimate by a staggering 13.3%.